Ignite Creation Date:
2024-05-06 @ 2:57 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04471428
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-30
First Post:
2020-07-07
Brief Title:
Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1PD-1 Antibody and Platinum-Containing Chemotherapy
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-07
First Submit QC Date:
July 10 2020
Study First Post Date:
2020-07-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-12-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-09
Last Update Post Date:
2024-05-30
Last Update Post Date Type:
ACTUAL